Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CRYOxCELLence is a wellness and nutraceutical company focused on supplements formulated for use alongside cryotherapy. Public materials describe it as founded by Kai Stubbe and launched in 2019 with a product line intended to support different cryotherapy-related consumer goals. Its initial commercial products were branded SLIM, YOUTH, FOCUS, and SLEEP, positioned as application-specific nutritional supplements rather than prescription therapeutics. Based on the available evidence, CRYOxCELLence appears to be a consumer health brand operating in the cryotherapy and biohacking/wellness segment, not a drug-development biotech or pharmaceutical company. Information on formal clinical development, proprietary drug pipeline, financing, and corporate structure is limited in publicly accessible sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CRYOxCELLence.